Herpes simplex
☆ AI Dermatology — Free Service
ໃນປີ 2022 Stiftung Warentest ຜົນໄດ້ຮັບຈາກເຢຍລະມັນ, ຄວາມພໍໃຈຂອງຜູ້ບໍລິໂພກກັບ ModelDerm ແມ່ນຕໍ່າກວ່າການປຶກສາຫາລືທາງດ້ານການປິ່ນປົວທາງໂທລະສັບເລັກນ້ອຍເທົ່ານັ້ນ.
ໃນປີ 2022 Stiftung Warentest ຜົນໄດ້ຮັບຈາກເຢຍລະມັນ, ຄວາມພໍໃຈຂອງຜູ້ບໍລິໂພກກັບ ModelDerm ແມ່ນຕໍ່າກວ່າການປຶກສາຫາລືທາງດ້ານການປິ່ນປົວທາງໂທລະສັບເລັກນ້ອຍເທົ່ານັ້ນ.
ເຮັບສິມພລັກຊ.
Herpes simplex - ການຕິດເຊື້ອ Herpes simplex ໃນນິ້ວມືແມ່ນພົບເລື້ອຍໃນເດັກນ້ອຍຫຼາຍກ່ວາຜູ້ໃຫຍ່.
relevance score : -100.0%
Referencesການຕິດເຊື້ອ HSV-1 ມີຄວາມຄືບຫນ້າໂດຍຜ່ານການຕິດເຊື້ອເບື້ອງຕົ້ນຂອງຊັດຕະພາບອັບພິລີຍະ (epithelial), ຕິດຕາມມາດ້ວຍການ latency, ສ່ວນໃຫຍ່ແມ່ນຢູ່ໃນນູໂຣນ, ແລະ reactivation. HSV-1 ໂດຍທົ່ວໄປແລ້ວເຮັດໃຫ້ເກີດການລະເບີດຂອງ vesicular ເບື້ອງຕົ້ນແລະເກີດຂຶ້ນເລື້ອຍໆ, ສ່ວນໃຫຍ່ແມ່ນຢູ່ໃນພື້ນທີ່ອໍໂຣລາບຽວ (orolabial). ການສະແດງຂອງມັນຕັ້ງແຕ່ພະຍາດ herpes orolabial ໄປສູ່ສະພາບຕ່າງໆເຊັ່ນ: herpetic folliculitis (herpetic folliculitis), herpetic whitlow (herpetic whitlow), ocular herpes (ocular herpes), ແລະກໍລະນີຮ້າຍແຮງເຊັ່ນ: herpes encephalitis. ການປິ່ນປົວດ້ວຍຢາຕ້ານໄວຣັສຊ່ວຍຈັດການການຕິດເຊື້ອ HSV.
Herpes simplex virus type 1 (HSV-1) is a member of the Alphaherpesviridae subfamily. Its structure is composed of linear dsDNA, an icosahedral capsid that is 100 to 110 nm in diameter, with a spikey envelope. In general, the pathogenesis of HSV-1 infection follows a cycle of primary infection of epithelial cells, latency primarily in neurons, and reactivation. HSV-1 is responsible for establishing primary and recurrent vesicular eruptions, primarily in the orolabial and genital mucosa. HSV-1 infection has a wide variety of presentations, including orolabial herpes, herpetic sycosis (HSV folliculitis), herpes gladiatorum, herpetic whitlow, ocular HSV infection, herpes encephalitis, Kaposi varicelliform eruption (eczema herpeticum), and severe or chronic HSV infection. Antiviral therapy limits the course of HSV infection.
Herpes simplex virus type 1 (HSV-1) is a member of the Alphaherpesviridae subfamily. Its structure is composed of linear dsDNA, an icosahedral capsid that is 100 to 110 nm in diameter, with a spikey envelope. In general, the pathogenesis of HSV-1 infection follows a cycle of primary infection of epithelial cells, latency primarily in neurons, and reactivation. HSV-1 is responsible for establishing primary and recurrent vesicular eruptions, primarily in the orolabial and genital mucosa. HSV-1 infection has a wide variety of presentations, including orolabial herpes, herpetic sycosis (HSV folliculitis), herpes gladiatorum, herpetic whitlow, ocular HSV infection, herpes encephalitis, Kaposi varicelliform eruption (eczema herpeticum), and severe or chronic HSV infection. Antiviral therapy limits the course of HSV infection.
Herpes simplex virus type 2 (HSV-2) ເປັນການຕິດເຊື້ອທີ່ແຜ່ຫຼາຍ, ສົ່ງຜົນກະທົບຕໍ່ປະມານ 22% ຂອງຜູ້ໃຫຍ່ທີ່ມີອາຍຸ 12 ປີຂຶ້ນໄປ, ຈໍານວນທັງຫມົດ 45 ລ້ານຄົນໃນສະຫະລັດ. ໃນຂະນດທີ່ HSV-1 ມັກຈະເຮັດໃຫ້ເກີດບາດແຜໃນຊ່ອງປາກ, ມັນຍັງສາມາດນໍາໄປສູ່ການບາດແຜຂອງອະໄວຍະວັດ. ຢ່າງໃດກໍຕາມ, ເມື່ອຄົນເຈັບມີບາດແຜຂອງອະໄວຍະວັດ, HSV-2 ມັກຈະເປັນຄວາມກັງວົນຕົ້ນຕໍ. ອາການຂອງການຕິດເຊື້ອ HSV-2 ມັກຈະບໍ່ຊັດເຈນ, ເຊັ່ນອາການຄັນ ແລະ ບວມທີ່ແຕກເຮັດໃຫ້ເກີດປະຕິເສດແຜລະບາດຂະໜາດນ້ອຍ.
Herpes simplex virus type 2 (HSV-2) continues to be a common infection, affecting approximately 22% of adults ages 12 and older, representing 45 million adults in the United States alone. While HSV-1 often affects the perioral region and can be known to cause genital lesions, HSV-2 is more commonly the consideration when patients present with genital lesions. Despite this, most outbreaks of the infection will present with nonspecific symptoms such as genital itching, irritation, and excoriations, which may cause diagnosis and treatment to be delayed. As a result, further exposure to uninfected individuals may occur.
Herpes simplex virus type 2 (HSV-2) continues to be a common infection, affecting approximately 22% of adults ages 12 and older, representing 45 million adults in the United States alone. While HSV-1 often affects the perioral region and can be known to cause genital lesions, HSV-2 is more commonly the consideration when patients present with genital lesions. Despite this, most outbreaks of the infection will present with nonspecific symptoms such as genital itching, irritation, and excoriations, which may cause diagnosis and treatment to be delayed. As a result, further exposure to uninfected individuals may occur.
Herpes simplex virus (HSV) ໂດຍທົ່ວໄປແລ້ວເຮັດໃຫ້ເກີດການຕິດເຊື້ອເຊັ່ນ: ອອກປາກ (oral) ແລະ ພັດແຜ່ນ (genital) ໃນວິຣັດ (viral) ແລະ ຜູ່ໃຫຍ່. ເມື່ອ HSV ຕິດເຊື້ອເດັກນ້ອຍພາຍໃນ 4-6 ອາທິດທໍາອິດຂອງຊີວິດ, ມັນສາມາດເຮັດໃຫ້ເກີດພະຍາດຮ້າຍແຮງທີ່ມີຜົນສະທ້ອນທີ່ຮ້າຍແຮງ. ການວິນິດໄສຢ່າງໄວເພື່ອປ້ອງກັນການຕິດເຊື້ອ HSV ຂອງເດັກໃໝ່ແມ່ນສໍາຄັນເພື່ອຢຸດບໍ່ໃຫ້ພະຍາດຮ້າຍແຮງຂຶ້ນ, ປ້ອງກັນບັນຫາທາງປະສາດ (ເຖິງແມ່ນວ່າການເສຍຊີວິດ).
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a well-known cause of infections including genital herpes and herpes labialis in the adolescent and adult population. Transmission of HSV infection to an infant during the first 4-6 weeks of life can lead to devastating disease with the potential for poor outcomes. Early diagnosis is imperative when evaluating neonatal HSV infection in order to prevent further disease progression, neurological complications, and even death.
Herpes simplex virus (HSV), a member of the Herpesviridae family, is a well-known cause of infections including genital herpes and herpes labialis in the adolescent and adult population. Transmission of HSV infection to an infant during the first 4-6 weeks of life can lead to devastating disease with the potential for poor outcomes. Early diagnosis is imperative when evaluating neonatal HSV infection in order to prevent further disease progression, neurological complications, and even death.
Herpes simplex ການຕິດເຊື້ອແມ່ນພົບເລິກຢ່າງບໍ່ຫນ້ອຍ ແລະສາມາດແຜ່ຈາກແມ່ຍິງທີ່ຖືພາໄປຫາລູກນ້ອຍ. ເຊື້ອໄວຣັດນີ້ອາດເຮັດໃຫ້ເກີດບັນຫາສຸຂະພາບທີ່ຮ້າຍແຮງ ຫຼື ອາດກໍ່ເຮັດໃຫ້ເສຍຊີວິດໃນເດັກເກີດໃໝ່. ໃນຂະນທີ່ມັນຫາຍາກໃນຂະຫຍັດການຖືພາ, ມັນມັກຈະເກີດຂຶ້ນໃນຂະຫຍັດຂອງການເກີດລູກ. ຄວາມສ່ຽງສູງທີ່ສຸດຖ້າແມ່ຕິດເຊື້ອໃນເວລາທີ່ກຳລັງຖືພາ. ຢ່າງໃດກໍ່ຕາມ, ຄວາມສ່ຽງນີ້ສາມາດຫຼຸດຜ່ອນໄດ້ໂດຍການໃຊ້ຢາຕ້ານໄວຣັດ ຫຼື ເລືອກ C-section ໃນບາງສະຖານການ.
Infection with herpes simplex is one of the most common sexually transmitted infections. Because the infection is common in women of reproductive age it can be contracted and transmitted to the fetus during pregnancy and the newborn. Herpes simplex virus is an important cause of neonatal infection, which can lead to death or long-term disabilities. Rarely in the uterus, it occurs frequently during the transmission delivery. The greatest risk of transmission to the fetus and the newborn occurs in case of an initial maternal infection contracted in the second half of pregnancy. The risk of transmission of maternal-fetal-neonatal herpes simplex can be decreased by performing a treatment with antiviral drugs or resorting to a caesarean section in some specific cases.
Infection with herpes simplex is one of the most common sexually transmitted infections. Because the infection is common in women of reproductive age it can be contracted and transmitted to the fetus during pregnancy and the newborn. Herpes simplex virus is an important cause of neonatal infection, which can lead to death or long-term disabilities. Rarely in the uterus, it occurs frequently during the transmission delivery. The greatest risk of transmission to the fetus and the newborn occurs in case of an initial maternal infection contracted in the second half of pregnancy. The risk of transmission of maternal-fetal-neonatal herpes simplex can be decreased by performing a treatment with antiviral drugs or resorting to a caesarean section in some specific cases.
Herpes simplex virus (HSV) ປະເພດ 1 ແລະ 2 ຕິດເຊື້ອຄົນທົ່ວໂລກ. ປົກກະຕິແລ້ວ, ໂວຍຣັດຈະງຽບຢູ່ໃນສາຍປະສາດຫຼັງຈາກການຕິດເຊື້ອຜິວຫນັງ, ແຕ່ມັນສາມາດ reactivate ຕໍ່ມາ, ເຊິ່ງກໍ່ໃຫ້ເກີດຄວາມເຢັນ. ບາງຄັ້ງ, ມັນນໍາໄປສູ່ບັນຫາຮ້າຍແຮງເຊັ່ນ: ການຕິດເຊື້ອທອງ (herpetic whitlow), ໂວຍຣັດຕາ (ocular herpes), ຫຼືໂວຍຣັດໂຕ່ຍ່ອຍ (neonatal herpes) ແລະ ຜູ່ແພດທີ່ມີລະບົບພູມຕ້ານ (immunocompromised patients). ໃນຂະນະທີ່ຢາໃນປະຈຸບັນຊ່ວຍຄວບຄຸມການຕິດເຊື້ອ, ຄວາມສ່ຽງຕໍ່ການດື້ຢາແລະຜົນຂ້າງຄຽງຍັງຄົງເປັນຄວາມກັງວົນ. ພວກເຮົາຕ້ອງການຢາໃຫມ່ເພື່ອເປົ້າຫມາຍເຊື້ອໄວຣັດທີ່ດີກວ່າ.
Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets.
Infection with herpes simplex virus (HSV) types 1 and 2 is ubiquitous in the human population. Most commonly, virus replication is limited to the epithelia and establishes latency in enervating sensory neurons, reactivating periodically to produce localized recurrent lesions. However, these viruses can also cause severe disease such as recurrent keratitis leading potentially to blindness, as well as encephalitis, and systemic disease in neonates and immunocompromised patients. Although antiviral therapy has allowed continual and substantial improvement in the management of both primary and recurrent infections, resistance to currently available drugs and long-term toxicity pose a current and future threat that should be addressed through the development of new antiviral compounds directed against new targets.
ເຊື້ອໄວຣັດ herpes simplex ມີສອງຊະນິດ, ປະເພດ 1 (HSV-1) ແລະປະເພດ 2 (HSV-2). HSV-1 ມັກຈະເຮັດໃຫ້ເກີດການຕິດເຊື້ອຮອບປາກໃນຂະນະທີ່ HSV-2 ມັກຈະເຮັດໃຫ້ເກີດການຕິດເຊື້ອທາງແພດ. ພວກມັນຖືກສົ່ງຜ່ານໂດຍການຕິດຕໍ່ໂດຍກົງກັບບຸກຄົນທີ່ຕິດເຊື້ອ. ອະໄວຍະວະເພດຖືກຈັດວ່າເປັນພະຍາດຕິດຕໍ່ທາງເພດສຳພັນ. ມັນອາດຈະແຜ່ລາມໄປຫາເດັກໃນເວລາເກີດລູກ. ຫຼັງຈາກການຕິດເຊື້ອ, ໄວຣັສຈະຖືກຂົນສົ່ງໄປຕາມເສັ້ນປະສາດ sensory ໄປຫາຮ່າງກາຍຂອງຈຸລັງເສັ້ນປະສາດ, ບ່ອນທີ່ພວກມັນອາໄສຢູ່ຕະຫຼອດຊີວິດ. ສາເຫດຂອງການເກີດຂຶ້ນຊ້ຳອາດປະກອບມີ: ການເຮັດວຽກຂອງພູມຄຸ້ມກັນຫຼຸດລົງ, ຄວາມກົດດັນ, ແລະການຖືກແສງແດດ.
ໃນກໍລະນີຫຼາຍທີ່ສຸດ, ຢາຕ້ານໄວຣັດແມ່ນໃຊ້ພຽງແຕ່ເມື່ອອາການຮ້າຍແຮງ. ຢາຕ້ານໄວຣັດປະຈໍາວັນອາດຈະຖືກກໍານົດໃຫ້ຜູ້ທີ່ຕິດເຊື້ອເລື້ອຍໆ. ບໍ່ມີຢາວັກຊີນທີ່ມີໃຫ້ ແລະ ວັກຊີນປ້ອງກັນໂຣກຫອບຫືດ (shingles) ບໍ່ໄດ້ປ້ອງກັນພະຍາດຫືດ. ການປິ່ນປົວດ້ວຍຢາຕ້ານໄວຣັດເຊັ່ນ: aciclovir ຫຼື valaciclovir ສາມາດຫຼຸດຜ່ອນຄວາມຮ້າຍແຮງຂອງອາການ.
ອັດຕາທົ່ວໂລກຂອງ HSV-1 ຫຼື HSV-2 ແມ່ນຢູ່ລະຫວ່າງ 60% ແລະ 95% ໃນຜູ້ໃຫຍ່. HSV-1 ມັກຈະຕິດເຊື້ອໃນໄວເດັກ. ປະມານ 536 ລ້ານຄົນໃນທົ່ວໂລກ (16% ຂອງປະຊາກອນ) ໄດ້ຕິດເຊື້ອ HSV-2 ໃນປີ 2003 ທີ່ມີອັດຕາຫຼາຍກວ່າແມ່ຍິງແລະຜູ້ທີ່ຢູ່ໃນປະເທດກໍາລັງພັດທະນາ. ຄົນສ່ວນໃຫຍ່ທີ່ມີ HSV-2 ບໍ່ຮູ້ວ່າພວກເຂົາຕິດເຊື້ອ.
○ ການປິ່ນປົວ ― OTC Drugs
ຫຼີກລ່ຽງການຕິດຕໍ່ທາງຮ່າງກາຍ, ເຊັ່ນການຈູບເດັກ, ໃນຂະນະທີ່ມີຕຸ່ມຜື່ນ, ຍ້ອນວ່າການຕິດຕໍ່ສາມາດແຜ່ເຊື້ອໄປສູ່ຜູ້ອື່ນໄດ້. ທ່ານຄວນພັກຜ່ອນໂດຍບໍ່ມີການດື່ມເຫຼົ້າ.
#Acyclovir cream